Disc Medicine, Inc.
No enriched coverage for $IRON in the last 7 days.
Quisel John D (Chief Executive Officer) sold 33,000 shares of Disc Medicine, Inc. (IRON) at an average of $79.15 ($78.11–$79.84, $2.61M total) across 3 trades on 2026-08-17 under a Rule 10b5-1 trading plan.
Bolt Metals Corp. will rebrand as 26 Metals Inc. and start trading on the CSE under ticker “IRON” at market open Aug. 19, 2026. The company says it is pivoting to advance its Florália Iron Project in Brazil’s Iron Quadrangle, including plans for drilling, resource work, and environmental permitting. It also appointed Rob Saltsman to the board.
Disc Medicine, Inc. (IRON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 iron-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update • Completed Type A meeting with the FDA on bitopertin and aligned that the Phase 3 APOLLO study, if successful, can serve as the basis f
Recent IRON coverage spans insider activity, corporate actions and earnings.
In the last 30 days, IRON insiders filed 5 SEC Form 4 transactions — no purchases and 5 sales ($3.1M). The most active reporter was Quisel John D, Chief Executive Officer, with 3 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
The filing is a new, company-specific insider-sale datapoint, but it is pre-arranged under a 10b5-1 plan, which typically reduces signal strength.
The primary tradable change is the new CSE ticker, which can affect order routing, watchlists, and sentiment.
New FDA alignment for bitopertin’s CRL response pathway plus updated Phase 2/2b clinical readouts and a long cash runway into 2029.
Production update likely improves near-term outlook and can drive momentum trading.
This is a routine insider sale under a 10b5-1 plan, so it is more useful for positioning and sentiment than for fundamental re-rating.
alphai scores every news story that mentions IRON with an AI model for sentiment and relevance, and aggregates insider trades from Disc Medicine, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Quisel John D (Chief Executive Officer) sold 33,000 shares of Disc Medicine, Inc. (IRON) at an average of $79.15 ($78.11–$79.84, $2.61M total) across 3 trades on 2026-08-17 under a Rule 10b5-1 trading plan.
1 min readBolt Metals Corp. will rebrand as 26 Metals Inc. and start trading on the CSE under ticker “IRON” at market open Aug. 19, 2026. The company says it is pivoting to advance its Florália Iron Project in Brazil’s Iron Quadrangle, including plans for drilling, resource work, and environmental permitting. It also appointed Rob Saltsman to the board.
4 min readDisc Medicine, Inc. (IRON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 iron-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update • Completed Type A meeting with the FDA on bitopertin and aligned that the Phase 3 APOLLO study, if successful, can serve as the basis f
5 min readThe article reports AIM takeover activity: Gooch & Housego PLC is being acquired in a £346m deal, and Ramsdens Holdings PLC is set to be bought for £230m. It also notes NextEnergy Solar rose 10% after putting itself up for sale, and highlights large AIM share moves for Ironveld, Itaconix, Jersey Oil and Gas, Safestay, Galileo Resources, and Iofina. Iofina reported 393.3 tonnes H1 2026 and raised guidance to 460-485 tonnes.
7 min readQuisel John D (Chief Executive Officer) sold 33,000 shares of Disc Medicine, Inc. (IRON) at an average of $74.96 ($74.27–$76.05, $2.47M total) across 3 trades on 2026-07-13 under a Rule 10b5-1 trading plan.
1 min readIronveld PLC (AIM:IRON) shares rose 32% to 0.025p after the company said its dense media separation plant reached sustained production. It now runs 16 hours daily on double shift, processing 2.5-3.5 tonnes per hour and producing 1.4 tonnes/hour in-spec magnetite plus about 1 tonne/hour maghemite. Three clients secured, with a 5,000 tonnes/month buyer sampling; expansion options and Mintek study ongoing.
3 min readDisc Medicine, Inc. (IRON) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. 8-K false 0001816736 0001816736 2026-06-25 2026-06-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25,
3 min readYu Jonathan Yen-Wen (Chief Operating Officer) sold 9,700 shares of Disc Medicine, Inc. (IRON) at $72.66 ($0.70M total) on 2026-06-22 under a Rule 10b5-1 trading plan.
2 min readDisc Medicine, Inc. (IRON) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001816736 0001816736 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18,
3 min readKhara Rahul (Chief Legal Officer) sold 7,500 shares of Disc Medicine, Inc. (IRON) at an average of $70.22 ($69.94–$71.62, $0.53M total) across 3 trades on 2026-06-18 under a Rule 10b5-1 trading plan.
2 min read